Stay informed with the latest updates for the inheritable blood disorders community. IndustryCSL Behring Announces Orphan Drug Designation for rFIX TherapyJul 1, 2012 IndustryNasalCEASE Gives Back to NHF ResearchJun 1, 2012 IndustryAchillion Begins Trial of New HCV Drug ACH-3102, Announces Fast Track…Jun 1, 2012 IndustryInspiration Files for Licensing of rFIX DrugMay 1, 2012 IndustryCSL Doses First Inhibitor Patients in Trial of New rFVII ProductMay 1, 2012 IndustryCSL Announces First Patient Screened for New rFVIII TrialApr 1, 2012 IndustryBayer Stresses Filtration Step for Kogenate FS UsersApr 1, 2012 IndustryREGENX/Chatham to Develop Genetically Based Hemophilia TherapiesApr 1, 2012 IndustryVertex Announces Interim Results of Telaprevir Studies in Co-Infected…Apr 1, 2012 IndustryOkairos Begins Next Phase of HCV Vaccine StudyApr 1, 2012 IndustryCSL Announces Site for Longer-Acting Recombinant FIX StudyFeb 1, 2012 IndustryAMT's Hemophilia B Gene Therapy Program Granted Orphan Drug StatusFeb 1, 2012 IndustryCatalyst Initiates Phase I Trial for rVIIa Product for InhibitorsFeb 1, 2012 IndustryAchillion's HCV Drug Receives Fast Track DesignationFeb 1, 2012 IndustryBaxter Announces Approval of ADVATE for Prophylaxis and Longer-…Jan 1, 2012 Pagination First page Previous page … Page 15 Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Next page Last page